Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of Clinical Dynamic Contrast-Enhanced Magnetic Resonance Imaging Perfusion Modeling and Neoadjuvant Chemotherapy Response Prediction in Breast Cancer Using 18FDG and 64Cu-DOTA-Trastuzumab Positron Emission Tomography Studies.
Whitman J, Adhikarla V, Tumyan L, Mortimer J, Huang W, Rockne R, Peterson JR, Cole J. Whitman J, et al. Among authors: adhikarla v. JCO Clin Cancer Inform. 2025 Jan;9:e2300248. doi: 10.1200/CCI.23.00248. Epub 2025 Jan 14. JCO Clin Cancer Inform. 2025. PMID: 39808751
Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma.
Zain J, Tsai NC, Palmer J, Simpson J, Adhikarla V, Bading JR, Yazaki P, Smith EP, Dandapani S, Song JY, Karras NA, Herrera AF, Salhotra A, Nademanee AP, Nakamura R, Smith DL, Yamauchi D, Poku EK, Biglang-Awa VE, Colcher D, Shively JE, Wu AM, Forman SJ, Wong J, Thomas S. Zain J, et al. Among authors: adhikarla v. Blood Adv. 2024 Sep 24;8(18):4812-4822. doi: 10.1182/bloodadvances.2023012497. Blood Adv. 2024. PMID: 38838232 Free PMC article. Clinical Trial.
Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers.
Kuznetsov M, Adhikarla V, Caserta E, Wang X, Shively JE, Pichiorri F, Rockne RC. Kuznetsov M, et al. Among authors: adhikarla v. bioRxiv [Preprint]. 2024 May 23:2024.05.22.595377. doi: 10.1101/2024.05.22.595377. bioRxiv. 2024. Update in: Cancer Res Commun. 2024 Nov 1;4(11):2955-2967. doi: 10.1158/2767-9764.CRC-24-0306 PMID: 38826403 Free PMC article. Updated. Preprint.
Targeting Wnt signaling for improved glioma immunotherapy.
Gutova M, Hibbard JC, Ma E, Natri HM, Adhikarla V, Chimge NO, Qiu R, Nguyen C, Melendez E, Aguilar B, Starr R, Yin H, Rockne RC, Ono M, Banovich NE, Yuan YC, Brown CE, Kahn M. Gutova M, et al. Among authors: adhikarla v. Front Immunol. 2024 Feb 21;15:1342625. doi: 10.3389/fimmu.2024.1342625. eCollection 2024. Front Immunol. 2024. PMID: 38449858 Free PMC article.
Neuroprotective potential of intranasally delivered L-myc immortalized human neural stem cells in female rats after a controlled cortical impact injury.
Amirbekyan M, Cheng JP, Adhikarla V, Moschonas EH, Bondi CO, Rockne RC, Kline AE, Gutova M. Amirbekyan M, et al. Among authors: adhikarla v. Res Sq [Preprint]. 2023 Sep 5:rs.3.rs-3242570. doi: 10.21203/rs.3.rs-3242570/v1. Res Sq. 2023. Update in: Sci Rep. 2023 Oct 19;13(1):17874. doi: 10.1038/s41598-023-44426-7 PMID: 37720043 Free PMC article. Updated. Preprint.
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma.
Awuah D, Minnix M, Caserta E, Tandoh T, Adhikarla V, Poku E, Rockne R, Pichiorri F, Shively JE, Wang X. Awuah D, et al. Among authors: adhikarla v. Cancer Immunol Immunother. 2023 Aug;72(8):2841-2849. doi: 10.1007/s00262-023-03461-z. Epub 2023 May 20. Cancer Immunol Immunother. 2023. PMID: 37209218 Free PMC article.
30 results